Approved by the FDA in 2022 for the treatment of type 2 diabetes, its a weekly injection thats proven so effective for weight loss that its been fast-tracked by the FDA for approval for treating obesity but has not been given the green light just yet
The most common include: Nausea Vomiting Diarrhea Constipation Fatigue Most side effects are mild and temporary
Read More On July 2324, 2026, FDAs Pharmacy Compounding Advisory Committee (PCAC) will review seven peptides for potential inclusion on the 503A Bulks List
**The views, opinions, and recommendations expressed in this essay are solely my own and do not represent the views, policies, or positions of any other organization with which I am affiliated
Indirect calorimetry Indirect calorimetry was carried out using a 16-chamber TSE PhenoMaster monitoring system (TSE Systems GmbH, Germany)
CONTACT: Email: [email protected]